Lilly's Greed Steered Course Over Zyprexa: Official
As the first state trial over Zyprexa begins to unfold, a former officer with the U.S. Food and Drug Administration has asserted that Eli Lilly & Co. brushed off the risks...To view the full article, register now.
Already a subscriber? Click here to view full article